This filing contains no new operational or financial data — it is a routine proxy solicitation for standard governance items. Traders should monitor the July 15, 2026 meeting outcome for any unexpected voting results but no near-term price catalyst is present. Watch for future 6-K filings for any material pipeline or clinical trial updates.
Price Chart
Executive Summary
PolyPid filed a 6-K furnishing proxy materials for its Annual and Extraordinary General Meeting on July 15, 2026. The meeting includes routine items (re-election of auditor and eight directors, approval of director compensation, discussion of FY2025 financials) and two compensation-related Special Majority votes: amending non-executive director option terms (9,132 options per director at a $4.46 exercise price) and granting 149,000 CEO options to Dikla Czaczkes Akselbrad at $4.46 per share. No material financial data, operational updates, or strategic catalysts are disclosed — this is a routine governance filing with no stock-moving information.
Key Facts
- Annual and Extraordinary General Meeting scheduled for July 15, 2026, at 2:00 p.m. Israel time
- Record date for voting is June 15, 2026
- Proposal 1: Re-elect EY (Kost Forer Gabbay & Kasierer) as independent auditor
- Proposal 2: Re-elect eight directors (Dikla Czaczkes Akselbrad, Brooke Story, Yechezkel Barenholz, Joseph BenAmram, Nir Dror, Yitzchak Jacobovitz, Itzhak Krinsky, Robert B. Stein) and approve their compensation
- Proposal 3: Amend non-executive director option terms — 9,132 options per director at $4.46 exercise price (30-day VWAP before May 11, 2026)
- Proposal 4: Grant 149,000 CEO options to Dikla Czaczkes Akselbrad at $4.46 per share, vesting quarterly over 4 years
- Proposal 5: Discuss FY2025 financial statements (no vote required)
- Chairman Brooke Story receives $75,000 fixed annual fee; non-Israeli directors get $20,000 annual fee; Israeli directors get NIS 37,000 (~$13,100) annual fee
- Mr. Jacobovitz waives director compensation
- This 6-K is incorporated by reference into five existing F-3 shelf registration statements and five S-8 registration statements
Financial Impact
No revenue, earnings, or cash flow figures disclosed. The option grants represent annual director compensation of $40,000 per non-executive director and CEO options for 149,000 shares at $4.46. At $87M market cap, potential full dilution from CEO options is ~$0.67M (under 1% of market cap) at the exercise price — immaterial.
Risk Factors
- Proxy vote failure on Special Majority items (Proposals 3 and 4) could cause minor governance friction but no material business impact
- Option grants add minor dilution (~149k CEO shares + ~54.8k non-executive director shares = ~203.8k total potential shares, likely under 3% of outstanding)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-067311 |
| Document: ea029409201ex99-3.htm | 0001213900-26-067311 |
| Document: ea0294092-6k_polypid.htm | 0001213900-26-067311 |
| Document: ea029409201ex99-1.htm | 0001213900-26-067311 |
| Document: 0001213900-26-067311-index-headers.html | 0001213900-26-067311 |
| Document: 0001213900-26-067311-index.html | 0001213900-26-067311 |
| Document: 0001213900-26-067311.txt | 0001213900-26-067311 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $4.90 | awaiting T+60 | — | $5.29 (+7.96%) |
Oct 1, 2026 25d ago | 6-K | $5.37 | awaiting T+60 | — | $5.29 (−1.49%) |
Oct 1, 2026 25d ago | Press Release | $5.37 | awaiting T+60 | — | $5.29 (−1.49%) |
Oct 1, 2026 25d ago | 6-K | $5.37 | awaiting T+60 | — | $5.29 (−1.49%) |
Oct 1, 2026 25d ago | Press Release | $5.37 | awaiting T+60 | — | $5.29 (−1.49%) |
Aug 12, 2026 10w ago | 6-K | $4.78 | awaiting T+60 | — | $5.29 (+10.67%) |
Aug 12, 2026 10w ago | 6-K | $4.84 | awaiting T+60 | — | $5.29 (+9.30%) |
Aug 12, 2026 10w ago | Press Release | $4.84 | awaiting T+60 | — | $5.29 (+9.30%) |
Jul 29, 2026 12w ago | 6-K | $4.08 $5.13 | ▲ +25.74% | ▲ +21.01% | $5.29 (+29.66%) |
Jul 21, 2026 13w ago | 6-K | $3.74 $4.83 | ▲ +29.14% | ▲ +26.30% | $5.29 (+41.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers